Company Search:
Advanced Search
Sponsored Links
Veloxis Pharmaceuticals A/S Company Snapshot
Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other miscellaneous service companies in Europe: Ose Immunotherapeutics SA of France (2018 sales of 24.46 million Euro [US$27.51 million] ), Molmed S.P.A. of Italy (28.45 million Euro [US$32.00 million] ), and Brain Biotechnology Research and Information Network AG which is based in Germany (29.05 million Euro [US$32.68 million] of which 65% was BioIndustrial).

Sales Analysis. During the year ended December of 2018, sales at Veloxis Pharmaceuticals A/S were 249.85 million Danish Kroner (US$37.63 million). This is an increase of 26.8% versus 2017, when the company's sales were 196.99 million Danish Kroner. This was the third consecutive year of growth at Veloxis Pharmaceuticals A/S.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Veloxis Pharmaceuticals A/S
  Stock Performance Chart for Veloxis Pharmaceuticals A/S
  Stock Data: Recent Stock Performance:
  Current Price (4/17/2019): 2.50
(Figures in Danish Kroner)
1 Week 3.5%   13 Weeks -1.6%  
4 Weeks 2.0%   52 Weeks 159.3%  
Veloxis Pharmaceuticals A/S Key Data:
  Ticker: VELO Country: Denmark
  Exchanges: CPH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 249,851,287
(Year Ending Jan 2019).
Employees: 55
  Currency: Danish Kroner Market Cap: 4,295,488,370
  Fiscal Yr Ends: December Shares Outstanding: 1,718,195,348
  Share Type: Stammaktie Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.